Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al
- PMID: 32471896
- DOI: 10.1136/annrheumdis-2020-217989
Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al
Keywords: arthritis; arthritis, infectious; gout.
Conflict of interest statement
Competing interests: AHJK reports grants from National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics, Inc and GlaxoSmithKline. JAS reports grants from NIH/NIAMS/National Institute of Allergy and Infectious Diseases/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute and the R. Bruce and Joan M. Mickey Research Scholar Fund, as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum. ERG and JWL have disclosed no conflicts of interest or competing interests.
Comment on
-
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.Ann Rheum Dis. 2020 Jun;79(6):734-736. doi: 10.1136/annrheumdis-2020-217480. Epub 2020 Apr 15. Ann Rheum Dis. 2020. PMID: 32295786 Free PMC article. No abstract available.
-
Case series of acute arthritis during COVID-19 admission.Ann Rheum Dis. 2021 Apr;80(4):e58. doi: 10.1136/annrheumdis-2020-217914. Epub 2020 May 29. Ann Rheum Dis. 2021. PMID: 32471899 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical